肺栓塞快速反应团队：指南演变、我们的机构模式及已发表文献的系统综述。
完整摘要 · 中文译文
肺栓塞（PE）仍然是心血管疾病发病和死亡的主要原因之一，在中高危和高危表现中，因血栓阻塞和缺氧诱导的血管收缩导致肺血管阻力增加而引起的右心室衰竭，驱动了不良结局。尽管影像学和治疗技术取得了进展，但关于抗凝以外升级治疗的指导有限，且各机构的管理策略仍存在很大差异。肺栓塞快速反应团队模式的建立旨在通过实时多学科评估和个体化治疗决策来弥补这些差距。本文总结了塑造当代肺栓塞诊疗的证据演变和指南推荐。
完整摘要 · 英文原文
Pulmonary embolism (PE) remains a leading cause of cardiovascular morbidity and mortality, with right ventricular failure, from increased pulmonary vascular resistance due to thrombus obstruction and hypoxia-induced vasoconstriction, driving adverse outcomes in intermediate-high and high-risk presentations. Despite advances in imaging and therapeutic technology, guidance on escalation beyond anticoagulation is limited, and management strategies continue to vary widely across institutions. The Pulmonary Embolism Response Team model was developed to address these gaps through real-time multidisciplinary evaluation and individualized treatment decisions. This article summarizes the evolution of evidence and guideline recommendations shaping contemporary PE care.